Fisher & Paykel Healthcare Board Chair Scott St John to retire in 2024

Fisher & Paykel Healthcare Board Chair Scott St John has announced his intention to retire from the Board with effect from the close of the company’s annual shareholders’ meeting in August this year. The Board has elected current director Neville Mitchell to succeed Mr St John as Chair.
Mr St John has held the role of Chair since August 2020 after joining the Board in 2015. It is generally expected that the company’s non-executive directors will serve for a total period, including re-elections, of approximately nine years.
Mr St John has led the Board during a transformational period for the company. Under his leadership, Fisher & Paykel Healthcare supplied products that helped millions of patients during the pandemic,  purchased land for a second New Zealand campus and expanded its manufacturing footprint in Mexico and China.
“I’m grateful to have played a part in the company’s growth trajectory and to have worked alongside an exceptional team,” said Mr St John. “Neville will be an excellent Board Chair. He has a strong track record in the medical devices industry and has outstanding corporate governance experience. I am confident the company will continue to thrive under his leadership.”
Mr Mitchell joined the Board of Fisher & Paykel Healthcare in November 2018 as an independent director. From 1995 to 2017, he was the Chief Financial Officer and Company Secretary of Cochlear, a global leader in implantable hearing solutions, and he played a key role in the company’s financial management and global expansion.
He is currently a non-executive director of Sonic Healthcare and Sigma Healthcare, and is a former director of The Board of Tax, South Eastern Sydney Local Health District, Osprey Medical and Sirtex Medical.
Mr Mitchell said it would be a privilege to lead the Board of Directors following Mr St John’s retirement.
“Fisher & Paykel Healthcare is a unique and innovative business, headquartered in New Zealand and with an unwavering commitment to understanding and meeting the needs of patients around the world. Scott has led the Board during a pivotal moment in the company’s history, and he has helped to build strong foundations for the future. I look forward to contributing to the company’s growth and success,” said Mr Mitchell.
The Board will commence a search to find a replacement director for Mr St John with the skills and experience to complement other members of the Board. Mr St John’s outstanding contribution to Fisher & Paykel Healthcare will be formally acknowledged at the annual shareholders’ meeting in August.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website


Media & Investor Contacts:

Karen Knott
GM Corporate Communications
+64 (0) 21 713 911


Dan Adolph
Head of Investor Relations
+64 (0) 22 511 4050

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board of Directors.